Premier High-THC Medical Cannabis Hub | GACP & GMP-Certified | 100% Vertically Integrated Colombian Opportunity
Acquire a "Top-Tier" global export hub at a 40% discount to invested capital. Secure a 36-month shortcut to market leadership with a turnkey, debt-free operation featuring €0.30/g production costs, an active EU offtake agreement, and proven export channels to Tier-1 markets.
Listing ID:
16289662234
Licence(s) Held:
GACP Certification (August 2025), TGA GMP Part I (Australia), and EU-GMP Part II approval (via Maltese partnership).
USD $7,000,000 O.B.O (100% share sale)
Listing Details:
Unbeatable Production Arbitrage
Ultra-Low Costs: All-in production costs of €0.30 per gram, with significant downward pressure as the facility reaches its 25+ tonne licensed capacity.
Elite Genetics: Proven high-THC cultivars (mid-20% THC) with sophisticated terpene profiles tailored for the European and Australian markets.
Ideal Climate: Located in a premier micro-climate offering consistent, predictable weather for year-round cultivation.
Institutional-Grade Infrastructure & Scalability
Immediate Capacity: 1.7 hectares of existing, interconnected greenhouses currently producing 5.7 tonnes of dried flower annually.
Expansion Ready: The 15-hectare site is fully licensed for 25+ tonnes, allowing for hyper-growth with minimal additional capex.
Operational Autonomy: Includes a dedicated on-site power sub-station with diesel backup and a 20,000 m³ rainwater reservoir with sophisticated water treatment plant.
Advanced Post-Harvest & Processing Tech
Dual-Track Facility: Separate, dedicated buildings for GACP post-harvest and strict EU-GMP/TGA GMP post-harvest/processing.
Unique Tech Edge: Equipped with Colombia’s only PLC 2500 purification system and a specialized X-ray sterilization system required for the Australian market.
On-Site Lab: Fully equipped laboratory for real-time potency and purity testing to ensure pharmaceutical-grade standards.
Validated Global Export Track Record
Proven Route to Market: One of only a handful of Colombian producers successfully exporting; approximately 1 tonne has already been delivered to European markets.
De-Risked Revenue: Sale includes a binding 3-year offtake agreement and established distribution relationships in Germany and the UK.
Turnkey Transition & Strategic Value
Investment Value: Over USD $12M in capital already deployed in infrastructure, licensing, and elite genetics.
Financial Status: Debt-Free.All related-party debt is forgiven at closing.
The "Shortcut": Bypasses the 3-year "dead period" typically lost to site selection, construction, and complex Colombian regulatory hurdles.
Management Continuity: The majority of the leadership team, including specialized production directors, will remain to ensure a seamless operational handover.
Tax Efficiency: Tax loss carry-forwards (~USD $1.5M) are available through 2036, surviving the share sale structure.
IDEAL BUYER PROFILE
This asset is a "Plug-and-Play" hub for EU, Canadian, or Australian operators looking to protect margins via low-cost supply, or Private Equity/Family Offices seeking a de-risked, asset-backed entry into the global medical cannabis sector.
16289662234
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
43743758395
Turnkey, UK medical cannabis importer, distributor & manufacturer with licensed packing/storage facility
A rare, ready-to-trade, multi-licensed, UK-based medical cannabis importer, wholesaler and manufacturer with processing hub. There are presently only a handful of other businesses in the UK with this specific combination of licensure and facility readiness.
